![Tom Holgate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Joseph Charles Holgate is currently a Director at BenevolentAI Cambridge Ltd. and a Director at BenevolentAI Technology Ltd. He previously worked as a Senior Vice President & Group Finance Director at BenevolentAI SA.
| Bedrijven | Functie | Begin |
|---|---|---|
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Directeur/Bestuurslid | 21-02-2018 |
BenevolentAI Technology Ltd.
 BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Develops AI based disease agnostic drug discovery platform | Directeur/Bestuurslid | 29-05-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BENEVOLENTAI S.A. | Financieel Directeur/CFO | 16-10-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Commercial Services |
BenevolentAI Technology Ltd.
BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Develops AI based disease agnostic drug discovery platform | Technology Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
